Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Boonstra

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Gynecologic Oncology|August 1, 1995
Cell biological markers of drug resistance in ovarian carcinomaA G van der Zee, H H Hollema, H W de Bruijn, et al.
American Journal of Nephrology|September 14, 2021
Impact of Polypharmacy on Health-Related Quality of Life in Dialysis PatientsJulia M T Colombijn, Anna A Bonenkamp, Anita van Eck van der Sluijs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancerR S de Jong, P H Willemse, H Boonstra, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2005
Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteinsMarieke den Brinker, Koen F M Joosten, Theo J Visser, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervixH W de Bruijn, J M Duk, A G van der Zee, et al.
British Journal of Cancer|June 1, 1995
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancerJ A Gietema, G J Veldhuis, H J Guchelaar, et al.
Clinical Endocrinology|February 21, 2004
GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trialN J T Arends, V H Boonstra, P G H Mulder, et al.
Nature Communications|November 21, 2025
A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo releaseOmnia M Elsharkasy, Charlotte V Hegeman, Tom A P Driedonks, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Gynecologic Oncology|August 1, 1995
Cell biological markers of drug resistance in ovarian carcinomaA G van der Zee, H H Hollema, H W de Bruijn, et al.
American Journal of Nephrology|September 14, 2021
Impact of Polypharmacy on Health-Related Quality of Life in Dialysis PatientsJulia M T Colombijn, Anna A Bonenkamp, Anita van Eck van der Sluijs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancerR S de Jong, P H Willemse, H Boonstra, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2005
Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteinsMarieke den Brinker, Koen F M Joosten, Theo J Visser, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervixH W de Bruijn, J M Duk, A G van der Zee, et al.
British Journal of Cancer|June 1, 1995
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancerJ A Gietema, G J Veldhuis, H J Guchelaar, et al.
Clinical Endocrinology|February 21, 2004
GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trialN J T Arends, V H Boonstra, P G H Mulder, et al.
Nature Communications|November 21, 2025
A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo releaseOmnia M Elsharkasy, Charlotte V Hegeman, Tom A P Driedonks, et al.
Pageof 8